Histologic transformation of lung cancer during pembrolizumab therapy: A case report

Por Xiaoyan Si, Yan You, Xiaotong Zhang, Hanping Wang, Mengzhao Wang, Li Zhang
Publicado em 2020-03-01

Successful treatment of pulmonary inflammatory myofibroblastic tumor with platinum‐pemetrexed: The first report of two cases

Por Xiaoyan Si, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Yan You, Li Zhang
Publicado em 2020-08-01

Treatment with or without bevacizumab as a first‐line and maintenance therapy for advanced non‐squamous non‐small cell lung cancer: A retrospective study

Por Jun, Ni, Hanping, Wang, Xiaoyan, Si, Yan, Xu, Mengzhao, Wang, Xiaotong, Zhang, Li, Zhang
Publicado no Thorac Cancer (2020)

Recommendations and exploration of diagnosis and treatment of critical and refractory immune checkpoint inhibitor‐associated adverse events

Por Peng Song, Hanping Wang, Xiaoyan Si, Xiaoxiao Guo, Yue Li, Jiaixin Zhou, Lian Duan, Li Zhang, Mengzhao Wang
Publicado em 2020-08-01

Clinical diagnosis and treatment of immune checkpoint inhibitors‐related endocrine dysfunction

Por Lian Duan, Linjie Wang, Hanping Wang, Xiaoyan Si, Li Zhang, Xiaowei Liu, Yue Li, Xiaoxiao Guo, Jiaxin Zhou, Huijuan Zhu, Li Zhang
Publicado em 2020-04-01

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis

Por Hanping Wang, Xiaoxiao Guo, Jiaxin Zhou, Yue Li, Lian Duan, Xiaoyan Si, Li Zhang, Xiaowei Liu, Mengzhao Wang, Juhong Shi, Li Zhang
Publicado em 2020-01-01

Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events

Por Junling ZHUANG, Jingting ZHAO, Xiaoxiao GUO, Jiaxin ZHOU, Lian DUAN, Wei QIU, Xiaoyan SI, Li ZHANG, Yue LI, Xiaowei LIU, Hanping WANG, Daobin ZHOU, Li ZHANG
Publicado em 2019-10-01